{"name":"Genome & Company","slug":"genome-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE42TTZJZV94UXdHdmEyQldydy1GNklUQWY5RnIxVTZGOFFaZU5YcFVjSC1WdGx3eWRzSERrU3lzaE5HeGFEbTFWNlFvWmR1Zm5jOThlSDZ1M1Zib3ZEOUczanY4a3AxV1hIa2tXZnJR0gFyQVVfeXFMTWVXMjRua0dKSVZhY3ZzTTduQ2ZNQUtnNnMtb1BuMnEtSEpOSDV0R3hDNEIzLW5Bb0VlQkY5M3ZMeVRjUThEXzNld2VfNkRDeEUySWZrNHhvOFdmVHJJRjc0ZWllMGVfbUlBYWJyY2REOUJR?oc=5","date":"2026-03-06","type":"pipeline","source":"koreabiomed.com","summary":"Genome & Company raises $20 mil. to push novel-target ADC pipeline - koreabiomed.com","headline":"Genome & Company raises $20 mil. to push novel-target ADC pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPbHhkUWxWeHE3cW9jbndiQUZNeEVqd004bkxqSmdZY2lFM01NMmlsa0ZCZkRaeGIzSzdoaHJPalVZQm5VcDJLN1h2OTl4RGNUSVhzQ3Z1QnVJT3p2MEttYVhtUmo3TXp3RFJtRmgxa3V6bWlvY2NURlc4cHNwdlpGSTVRbU1xT2JIWVJob2Vtaw?oc=5","date":"2026-02-05","type":"pipeline","source":"The Motley Fool","summary":"Best Genomics Stocks of 2026: Are They Right for Your Portfolio? - The Motley Fool","headline":"Best Genomics Stocks of 2026: Are They Right for Your Portfolio?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE14SXBwT2lCdzZzT0t2MVNsRTBadkh0czFGN1ozSmdjb0JqeEx5ZEx6UEZFWEg5Q2pSRnpndXJpWG43cVIySjFyZjA2NnQ1VnBqcHJxX1ZyUjNDekZzZmJ0OS1pNnBaNmowMExwa3F30gFyQVVfeXFMTm8xVGxsdlpSVzQybmVUbmQxRFNvTzdSXzlSQ2xGR1FMalRZLVF0cUFSQmd3c2ExRy1OT1BoYTlEVDExQUZUdFVWQmtrYmwtWTVSZ0tYLVZkbWZxWGZ0S0xiOW9kaGNUdzJHc3NtQlpwOFhR?oc=5","date":"2025-11-12","type":"trial","source":"koreabiomed.com","summary":"Genome & Company completes CSR for phase 2 trial of GEN-001 in gastric cancer - koreabiomed.com","headline":"Genome & Company completes CSR for phase 2 trial of GEN-001 in gastric cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE82VTZxNGcyNGVKaDRsUHlSeTF5ay1XMW9oV2VjOW1zNENKTzMxcXg4bmlaZUduX1pIVHNfa3oyTUFWYVdMSFBpb3l6cTl3aDN0TmdBT3lBRC1ub1gyTm4wSXEtZ1lEVnBVRloybkx30gFyQVVfeXFMTWFGTHZ0bXRHR29uUjJvMm0ta2NTRTNvVUw5YXpSc1c3UnZiSnpPdGlPRlNoTWVyNnpYSmRnQUpuSVFycGNqSzBmOGt5Zzh3ZW9hRDQ5V2RsMUtRaGY3UWtuSlRkY1QzOUtxRXBISmhiUDJB?oc=5","date":"2025-06-24","type":"pipeline","source":"koreabiomed.com","summary":"Genome & Company shifts business strategy from microbiome to ADCs - koreabiomed.com","headline":"Genome & Company shifts business strategy from microbiome to ADCs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPUlhnS0wtTDgwQnUwc2tlU040TWlCc0x2Zno5dElDanhuX3M4eGlpcUVYRmNLSUVFcFk4Q2JqVE9TR2RKX2drTUMwSzMySWNpbkFtdnRkNjlkeEhzZ1IxNVB4eW8xV1NPSnYzZnpOU3dzUTNwQllGdDZ0UzdHTDNBQlpSZV9JcHdlTFZDdHo5WGJDR0FkaFlJYUUxWk1lSUNHM0ZwWUVJZw?oc=5","date":"2025-04-15","type":"pipeline","source":"The Business Journals","summary":"Fast-growing British firm opens North Carolina office - The Business Journals","headline":"Fast-growing British firm opens North Carolina office","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPajFfbGdqdWlqVFFYUjB5WUxxb2xweF9iMmg2bW1sbTJNSWtkRkJTbkV5aHNKWFFvMTJkdGtYZ01rZ3pmQ3AyeFJlZG1wZENVZl9TRUoxTEY1MTNsZTExcU5oQ09VOUR0YXRQeXZ6dGd6aEhoUW1Lck5WOFMza3IwdlBlQlM2VXhWSVNEYXp2TjBwN1dxYlVWZWp3ZTlKT0JIYUhTakVJUTNVUQ?oc=5","date":"2025-02-18","type":"deal","source":"BioWorld News","summary":"APAC deals abound: Lilly taps Advancell, Olix; Genome draws Ellipses - BioWorld News","headline":"APAC deals abound: Lilly taps Advancell, Olix; Genome draws Ellipses","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPVzEza3N6MmNGZ3B0Y2oxdFo3ZjhYX3hpQjhmVThGODNQams0eHM3QmJyWTdoeW9VRmI4b2hyd01EUTBySkUzUGFiOXRYTVV0NTUxNVIwTFFuMUlHWGlGVnZBVEhTODJlN1lYdExVdklpR0xmdnQwWkl0c1FiSEpiLWk2TUZtdDJQejF3S0Z0X0VPTFZiUG9jUENqZmxrQkRtT0NEcTlZcF9sWm83ZmlsU3AtSHpwTGhlOHFHT0s4XzlnNUo1MU5jSnVMRDRQVmNuX05HNDl0eDZEdHluVk53b0hPa2lQZGZsQ1NFS0tqM1V1UQ?oc=5","date":"2025-02-11","type":"pipeline","source":"BioSpace","summary":"Ellipses In-Licences First in Class Novel Immuno-Oncology Agent With Potential as a Next Generation Checkpoint Inhibitor - BioSpace","headline":"Ellipses In-Licences First in Class Novel Immuno-Oncology Agent With Potential as a Next Generation Checkpoint Inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNSmRrMzFkZDI3aHBEQnVMY09RSXpoSnQtblpUck9sbTljRjdTSlczU19WZ3NtemZqV3FDMW9pQVFGbXdvRXI4WS1mblpxTUN6QlZKcG5icDJ1RzF1eHZKS2tOZ3MtTEtSSlZnMlA3WURVZWFlWkFPTDR0T3BkUFB1RXFHT2JGWjBaZ1ZKbWRvTkVGbmtQZHFVQmRiSWYwQlpDVWhTeFRKZ2ZvRExEbDNQN3pGclJlbmlkQmE2RXVubw?oc=5","date":"2025-01-13","type":"deal","source":"NVIDIA Newsroom","summary":"NVIDIA Partners With Industry Leaders to Advance Genomics, Drug Discovery and Healthcare - NVIDIA Newsroom","headline":"NVIDIA Partners With Industry Leaders to Advance Genomics, Drug Discovery and Healthcare","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNN1BKUlpnb0Q2TGFXTUtVZURmMWh6WjExYlBlbFN2MENnRGdhajU4NmxYVjUwN3pLNUNRMGpyMUNEcExOcVZJbzZKS3cyUC0xNlNUSTlEM1I3aENZbDRVR0dRNHhGWHJ0UnV0QUxnSGVsSHJBb0JVZFJDOHlIaWs5RUxoWkRsc3B4MUItQlIwMDV4R3dQVWY0ai1La1JUNFAxam5LaTNYM1U5QzJxalVSaVhGNjMxRlhEdXYtWFVQbmI?oc=5","date":"2024-05-22","type":"pipeline","source":"genomicsengland.co.uk","summary":"James Duboff: Genomics 101 - How do pharmaceutical companies use… - genomicsengland.co.uk","headline":"James Duboff: Genomics 101 - How do pharmaceutical companies use…","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQRXp0WnFOdU1UOGRQQ3Q3WEs0b21IbG8wVk8zUk40UTFVSE9DdUgtbHRSdEMzN1RkMzhUbm9XbnlfUVB5SUp4bnJTMkJfZ29FNnk5WUxzb0hCVlZOSEhnbUpJcWc3ckhPeGZub3pYSTN3Rnh1M1hqaTNXRzdtWDJNMzFvU3dubzhDaGRmWWkwZWN6SFlXdlVBc3pFQlNIVlJJYWVpUno0OVJmQi1nYTFxVXBKVVdtVDM2QmFiR2VEWlZDZw?oc=5","date":"2024-02-06","type":"pipeline","source":"Inside Precision Medicine","summary":"10 Leading Specialists in Comprehensive Genomic Profiling - Inside Precision Medicine","headline":"10 Leading Specialists in Comprehensive Genomic Profiling","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPcWJmRGZrZjRjOWduM29kNEJsTDNRbHhSa2ZyeWU5V3ZhcFotTU9iT0dTanlXZ2F0M0N5OExsWTZqS1A0TGwybXkzVm1WMmRhVGs1WjNXT2FmMHBNbXhPbzM2X3MxdkFHbzVKUXh6NDRyUHEwSTFmZ2R1X3I0TDdEanlyclo3M3d1LW4zNG41NTV3VUFTcjJSRmdlTUh3S0g1UXdXaDJEY214eVNpdDhFX3pPWFY?oc=5","date":"2023-09-12","type":"pipeline","source":"Pharmaceutical Technology","summary":"J&J and BMS invest in dark genome-focused company Rome Therapeutics - Pharmaceutical Technology","headline":"J&J and BMS invest in dark genome-focused company Rome Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPMkQ3eWVGNjJhdkp0SW9udllEYlFUbC1HenVYTVJ4ZWs1bng1UERUb191WFJ6RG1Sb1liZE1GQWhobmJwU1ViNHk3YlowSEUwSFNTYkNmN1o5MEs0WDktX1NxQzZEMGRsVGZiUmNTNlQyNmxxMWNaZDcxdW1hSEx4S2FYTVN3OTJCVTFuY2dCWEhMWnVtLXc0bUw0NXhVSmNYYVlzMUVn?oc=5","date":"2021-11-16","type":"pipeline","source":"Fierce Pharma","summary":"List Bio to build new $125M microbiome plant in Indiana, hire 210 - Fierce Pharma","headline":"List Bio to build new $125M microbiome plant in Indiana, hire 210","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}